3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
171
Fallopian Tube Neoplasms
85
Uterine Cervical Neoplasms
40
Carcinoma, Ovarian Epithelial
28
Endometrial Neoplasms
27
Neoplasms
14
Peritoneal Neoplasms
10
Colorectal Neoplasms
9
Brenner Tumor
9
Breast Neoplasms
9
Stomach Neoplasms
8
Recurrence
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Lung Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Carcinoma
5
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
4
Carcinoma, Hepatocellular
4
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Ovarian Diseases
3
Melanoma
3
Glioblastoma
3
Carcinoma, Renal Cell
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Vaccinia
2
Uterine Neoplasms
2
Urinary Bladder Neoplasms
2
Interventions
Paclitaxel
2
sagopilone
1
allantoicase
1
Vitamin B Complex
1
Sodium Selenite
1
Sodium Chloride
1
Saline Solution
1
Prednisolone
1
Physical Therapy Modalities
1
Omacor
1
Low-Level Light Therapy
1
Fish Oils
1
Fatty Acids, Omega-3
1
Drug Therapy
1
Carboplatin
1
Bevacizumab
1
BID protein, human
1
Amifostine
1
Acetylcarnitine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peripheral Nervous System Diseases
×
Bevacizumab
×
Gynecologic
×
Clear all
NCT04201561
2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3
Unknown
68 enrolled